To determine whether the mechanism by which the combination works in a second hormone-sensitive PCa cell line PC-346 C [49] is similar to that in LNCaP cells, we tested the effects of these treatments on EGFR, HER2 and ErbB3. This evidence concerns the gene EGFR and posterior cortical atrophy.